News | November 08, 2022
SeQuent Scientific to acquire 100% stake in Tineta Pharma
The acquisition is for an enterprise value of Rs. 218 crores
The acquisition is for an enterprise value of Rs. 218 crores
The combination of Optym, Emmes' ophthalmology certification unit, and Clinical Edge will make the organization a leader in ophthalmic certification and training services
With this acquisition, UBC provides the most comprehensive REMS services and innovative risk mitigation solutions for the biopharmaceutical industry
It celebrated its 100th session as LPC-100 in association with Mundial Pharma
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
Fiscal support in line with what is available in key innovation hubs such as USA and China will drive the next leg of drug discovery in India
Incorporating multi-modality image guidance, Ethos therapy provides the ability to personalize the patient's treatment based on their anatomy and position at the time of treatment
The pandemic has provided tailwinds in terms of access to rural healthcare and India’s emergence as a vaccine powerhouse
Subscribe To Our Newsletter & Stay Updated
